SIMILAR PATTERNS OF AMINO ACIDS FOR 3FC6_A_REAA501_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dqu ISOCITRATE LYASE

(Aspergillus
nidulans)
PF00463
(ICL)
5 ILE A 166
ALA A 192
ALA A 191
LEU A  59
ALA A  56
None
0.92A 3fc6A-1dquA:
undetectable
3fc6A-1dquA:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fc4 2-AMINO-3-KETOBUTYRA
TE CONENZYME A
LIGASE


(Escherichia
coli)
PF00155
(Aminotran_1_2)
5 ILE A 238
ALA A 255
ALA A 256
LEU A 100
ALA A  97
None
0.92A 3fc6A-1fc4A:
undetectable
3fc6A-1fc4A:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kbl PYRUVATE PHOSPHATE
DIKINASE


([Clostridium]
symbiosum)
PF00391
(PEP-utilizers)
PF01326
(PPDK_N)
PF02896
(PEP-utilizers_C)
5 ILE A 368
ALA A 370
LEU A 864
ALA A 865
ILE A 359
None
0.97A 3fc6A-1kblA:
undetectable
3fc6A-1kblA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lv7 FTSH

(Escherichia
coli)
PF00004
(AAA)
5 ILE A 256
GLN A 319
PHE A 316
LEU A 306
ILE A 219
None
1.00A 3fc6A-1lv7A:
undetectable
3fc6A-1lv7A:
24.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n60 CARBON MONOXIDE
DEHYDROGENASE SMALL
CHAIN


(Oligotropha
carboxidovorans)
PF00111
(Fer2)
PF01799
(Fer2_2)
5 ILE A 149
ALA A 152
ALA A 153
LEU A  90
ALA A  89
None
0.93A 3fc6A-1n60A:
undetectable
3fc6A-1n60A:
19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmo HYPOTHETICAL PROTEIN
YBGI


(Escherichia
coli)
PF01784
(NIF3)
5 ILE A 179
ALA A 182
ALA A 183
ALA A 169
ILE A 200
None
1.01A 3fc6A-1nmoA:
undetectable
3fc6A-1nmoA:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1prz RIBOSOMAL LARGE
SUBUNIT
PSEUDOURIDINE
SYNTHASE D


(Escherichia
coli)
PF00849
(PseudoU_synth_2)
5 ILE A 236
ALA A 173
LEU A 279
ALA A 278
ILE A 189
None
1.01A 3fc6A-1przA:
undetectable
3fc6A-1przA:
21.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1uhl RETINOIC ACID
RECEPTOR RXR-BETA


(Homo sapiens)
PF00104
(Hormone_recep)
11 ILE A 339
ALA A 342
ALA A 343
GLN A 346
TRP A 376
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
None
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
0.59A 3fc6A-1uhlA:
30.3
3fc6A-1uhlA:
88.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ukw ACYL-COA
DEHYDROGENASE


(Thermus
thermophilus)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 ILE A 117
ALA A 120
LEU A 150
ALA A 151
ILE A  55
None
0.91A 3fc6A-1ukwA:
undetectable
3fc6A-1ukwA:
21.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xiu RXR-LIKE PROTEIN

(Biomphalaria
glabrata)
PF00104
(Hormone_recep)
11 ILE A 242
ALA A 245
ALA A 246
GLN A 249
TRP A 279
PHE A 287
ARG A 290
LEU A 300
ALA A 301
ILE A 319
CYH A 406
9CR  A 201 ( 4.4A)
9CR  A 201 (-3.6A)
9CR  A 201 (-3.6A)
9CR  A 201 (-4.1A)
None
9CR  A 201 (-4.7A)
9CR  A 201 (-2.8A)
9CR  A 201 (-4.4A)
9CR  A 201 (-3.4A)
None
9CR  A 201 (-3.6A)
0.40A 3fc6A-1xiuA:
30.7
3fc6A-1xiuA:
81.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xls RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
PF00104
(Hormone_recep)
11 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
0.42A 3fc6A-1xlsA:
30.0
3fc6A-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1z5x ULTRASPIRACLE
PROTEIN (USP) A
HOMOLOGUE OF RXR


(Bemisia tabaci)
PF00104
(Hormone_recep)
5 ILE U 303
ALA U 306
ALA U 307
LEU U 365
ALA U 362
None
0.83A 3fc6A-1z5xU:
22.1
3fc6A-1z5xU:
63.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zk7 MERCURIC REDUCTASE

(Pseudomonas
aeruginosa)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ALA A 452
ALA A 451
GLN A 453
LEU A 434
ALA A 435
None
None
GOL  A3003 ( 3.8A)
None
None
0.95A 3fc6A-1zk7A:
undetectable
3fc6A-1zk7A:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g4r MOLYBDOPTERIN
BIOSYNTHESIS MOG
PROTEIN


(Mycobacterium
tuberculosis)
PF00994
(MoCF_biosynth)
5 ILE A  67
ALA A   6
LEU A  32
ILE A  99
CYH A 117
None
0.99A 3fc6A-2g4rA:
undetectable
3fc6A-2g4rA:
21.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2gl8 RETINOIC ACID
RECEPTOR RXR-GAMMA


(Homo sapiens)
PF00104
(Hormone_recep)
7 TRP A  84
PHE A  92
ARG A  95
LEU A 105
ALA A 106
ILE A 124
CYH A 211
None
0.82A 3fc6A-2gl8A:
28.1
3fc6A-2gl8A:
85.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ist RIBOSOMAL LARGE
SUBUNIT
PSEUDOURIDINE
SYNTHASE D


(Escherichia
coli)
PF00849
(PseudoU_synth_2)
PF01479
(S4)
5 ILE A 236
ALA A 173
LEU A 279
ALA A 278
ILE A 189
None
1.02A 3fc6A-2istA:
undetectable
3fc6A-2istA:
21.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2nxx ULTRASPIRACLE (USP,
NR2B4)


(Tribolium
castaneum)
PF00104
(Hormone_recep)
5 PHE A 259
ARG A 262
LEU A 272
ALA A 273
CYH A 378
None
0.71A 3fc6A-2nxxA:
24.8
3fc6A-2nxxA:
63.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o7a LYSOZYME

(Escherichia
virus T4)
PF00959
(Phage_lysozyme)
5 ALA A 129
PHE A 153
LEU A 133
ALA A 130
ILE A  78
None
1.01A 3fc6A-2o7aA:
undetectable
3fc6A-2o7aA:
23.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p6w PUTATIVE
GLYCOSYLTRANSFERASE
(MANNOSYLTRANSFERASE
) INVOLVED IN
GLYCOSYLATING THE
PBCV-1 MAJOR CAPSID
PROTEIN


(Paramecium
bursaria
Chlorella virus
1)
PF05637
(Glyco_transf_34)
5 ILE A  61
ALA A  64
ALA A  65
LEU A   9
ILE A 132
None
0.79A 3fc6A-2p6wA:
undetectable
3fc6A-2p6wA:
23.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2q60 RETINOID X RECEPTOR

(Polyandrocarpa
misakiensis)
PF00104
(Hormone_recep)
6 TRP A 180
PHE A 188
ARG A 191
ALA A 202
ILE A 220
CYH A 307
None
0.62A 3fc6A-2q60A:
28.3
3fc6A-2q60A:
72.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q8w POKEWEED ANTIVIRAL
PROTEIN


(Phytolacca
acinosa)
PF00161
(RIP)
5 ILE A 214
ALA A 217
ARG A 240
LEU A 222
ALA A 221
None
0.96A 3fc6A-2q8wA:
undetectable
3fc6A-2q8wA:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qb0 TELSAM DOMAIN -
LYSOZYME CHIMERA


(Escherichia
virus T4)
PF00959
(Phage_lysozyme)
PF02198
(SAM_PNT)
5 ALA B 222
PHE B 246
LEU B 226
ALA B 223
ILE B 171
None
0.97A 3fc6A-2qb0B:
undetectable
3fc6A-2qb0B:
24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z1p COLLAGEN ADHESIN
PROTEIN


(Enterococcus
faecalis)
PF05737
(Collagen_bind)
5 GLN A 246
PHE A 244
LEU A 241
ALA A 242
ILE A 209
None
1.00A 3fc6A-2z1pA:
undetectable
3fc6A-2z1pA:
19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3afg SUBTILISIN-LIKE
SERINE PROTEASE


(Thermococcus
kodakarensis)
PF00082
(Peptidase_S8)
PF04151
(PPC)
6 ILE A 368
ALA A 415
ALA A 416
LEU A 388
ALA A 387
ILE A 143
None
1.22A 3fc6A-3afgA:
undetectable
3fc6A-3afgA:
17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3al0 ASPARTYL/GLUTAMYL-TR
NA(ASN/GLN)
AMIDOTRANSFERASE
SUBUNIT B


(Thermotoga
maritima)
PF02637
(GatB_Yqey)
PF02934
(GatB_N)
5 ILE B  11
GLN B  14
LEU B 196
ALA B 195
ILE B 119
None
1.00A 3fc6A-3al0B:
undetectable
3fc6A-3al0B:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b89 16S RRNA METHYLASE

(Escherichia
coli)
PF07091
(FmrO)
5 ILE A 172
GLN A 192
TRP A 222
LEU A 194
ILE A 244
None
0.99A 3fc6A-3b89A:
undetectable
3fc6A-3b89A:
24.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c1o EUGENOL SYNTHASE

(Clarkia breweri)
PF05368
(NmrA)
5 ILE A  94
ALA A 141
LEU A 143
ALA A 142
ILE A  87
None
1.02A 3fc6A-3c1oA:
undetectable
3fc6A-3c1oA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cqf THIOL-ACTIVATED
CYTOLYSIN


(Bacillus
anthracis)
PF01289
(Thiol_cytolysin)
PF17440
(Thiol_cytolys_C)
5 ILE A 499
ALA A 417
GLN A 418
TRP A 441
ILE A 510
None
1.02A 3fc6A-3cqfA:
undetectable
3fc6A-3cqfA:
20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d8u PURR TRANSCRIPTIONAL
REGULATOR


(Vibrio
parahaemolyticus)
PF13377
(Peripla_BP_3)
5 ALA A 311
ALA A 310
LEU A  96
ALA A  95
ILE A  76
None
0.86A 3fc6A-3d8uA:
undetectable
3fc6A-3d8uA:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dme CONSERVED EXPORTED
PROTEIN


(Bordetella
pertussis)
PF01266
(DAO)
6 ILE A  10
ALA A 205
ALA A 204
LEU A 212
ALA A 209
ILE A   5
FAD  A 500 (-4.5A)
FAD  A 500 (-3.6A)
None
FAD  A 500 ( 4.3A)
None
None
1.25A 3fc6A-3dmeA:
undetectable
3fc6A-3dmeA:
21.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dzu RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
PF00104
(Hormone_recep)
PF00105
(zf-C4)
11 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
9CR  A7223 (-3.9A)
9CR  A7223 (-3.5A)
9CR  A7223 (-4.2A)
9CR  A7223 (-4.6A)
None
9CR  A7223 (-4.5A)
9CR  A7223 (-3.7A)
9CR  A7223 (-3.8A)
9CR  A7223 ( 4.7A)
9CR  A7223 ( 4.9A)
9CR  A7223 (-3.8A)
0.72A 3fc6A-3dzuA:
30.5
3fc6A-3dzuA:
51.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dzu RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
PF00104
(Hormone_recep)
PF00105
(zf-C4)
7 ILE A 268
ALA A 271
GLN A 275
PHE A 313
ARG A 316
ALA A 327
ILE A 345
9CR  A7223 (-3.9A)
9CR  A7223 (-3.5A)
9CR  A7223 (-4.6A)
9CR  A7223 (-4.5A)
9CR  A7223 (-3.7A)
9CR  A7223 ( 4.7A)
9CR  A7223 ( 4.9A)
1.50A 3fc6A-3dzuA:
30.5
3fc6A-3dzuA:
51.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h5k RIBOSOME-INACTIVATIN
G PROTEIN
PD-L1/PD-L2


(Phytolacca
dioica)
PF00161
(RIP)
5 ILE A 214
ALA A 217
ARG A 240
LEU A 222
ALA A 221
None
0.94A 3fc6A-3h5kA:
undetectable
3fc6A-3h5kA:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hve GIGAXONIN

(Homo sapiens)
PF00651
(BTB)
PF07707
(BACK)
5 ILE A  47
ALA A  50
ALA A  51
LEU B  20
ALA B  19
None
0.54A 3fc6A-3hveA:
undetectable
3fc6A-3hveA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hve GIGAXONIN

(Homo sapiens)
PF00651
(BTB)
PF07707
(BACK)
5 ILE B  47
ALA B  50
ALA B  51
LEU A  20
ALA A  19
None
0.67A 3fc6A-3hveB:
undetectable
3fc6A-3hveB:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ic5 PUTATIVE
SACCHAROPINE
DEHYDROGENASE


(Ruegeria
pomeroyi)
PF03435
(Sacchrp_dh_NADP)
5 ILE A  82
ALA A  85
ALA A  86
LEU A  60
ALA A  61
None
0.75A 3fc6A-3ic5A:
undetectable
3fc6A-3ic5A:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ipc ABC TRANSPORTER,
SUBSTRATE BINDING
PROTEIN (AMINO ACID)


(Agrobacterium
fabrum)
PF13458
(Peripla_BP_6)
5 ILE A 286
ALA A 289
ALA A 290
LEU A 305
ALA A 304
None
0.66A 3fc6A-3ipcA:
undetectable
3fc6A-3ipcA:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3msu CITRATE SYNTHASE

(Francisella
tularensis)
PF00285
(Citrate_synt)
5 ALA A 175
ALA A 176
LEU A 388
ALA A 384
ILE A 218
None
0.93A 3fc6A-3msuA:
undetectable
3fc6A-3msuA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o0m HIT FAMILY PROTEIN

(Mycolicibacterium
smegmatis)
PF01230
(HIT)
5 ILE A  67
ALA A  70
ALA A  71
LEU A 136
ALA A 135
None
0.53A 3fc6A-3o0mA:
undetectable
3fc6A-3o0mA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oks 4-AMINOBUTYRATE
TRANSAMINASE


(Mycolicibacterium
smegmatis)
PF00202
(Aminotran_3)
5 ILE A 327
ALA A 331
ALA A 330
LEU A 298
ALA A 295
None
1.02A 3fc6A-3oksA:
undetectable
3fc6A-3oksA:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pbl D(3) DOPAMINE
RECEPTOR, LYSOZYME
CHIMERA


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 ALA A1129
PHE A1153
LEU A1133
ALA A1130
ILE A1078
None
1.02A 3fc6A-3pblA:
undetectable
3fc6A-3pblA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s5w L-ORNITHINE
5-MONOOXYGENASE


(Pseudomonas
aeruginosa)
PF13434
(K_oxygenase)
5 ILE A 419
ALA A 416
LEU A  25
ALA A  24
ILE A 376
None
0.94A 3fc6A-3s5wA:
undetectable
3fc6A-3s5wA:
18.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3trh PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CARBOXYLTRANSFERASE
SUBUNIT


(Coxiella
burnetii)
PF00731
(AIRC)
5 ILE A  63
ALA A  64
ALA A  65
ALA A  73
ILE A 127
None
0.96A 3fc6A-3trhA:
undetectable
3fc6A-3trhA:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uc2 HYPOTHETICAL PROTEIN
WITH
IMMUNOGLOBULIN-LIKE
FOLD


(Pseudomonas
aeruginosa)
PF14467
(DUF4426)
5 ILE A  59
ALA A 103
GLN A 104
PHE A 105
LEU A  88
None
0.97A 3fc6A-3uc2A:
undetectable
3fc6A-3uc2A:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v2y SPHINGOSINE
1-PHOSPHATE RECEPTOR
1, LYSOZYME CHIMERA
(E.C.3.2.1.17)


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 ALA A1129
PHE A1153
LEU A1133
ALA A1130
ILE A1078
None
0.98A 3fc6A-3v2yA:
undetectable
3fc6A-3v2yA:
18.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3waj TRANSMEMBRANE
OLIGOSACCHARYL
TRANSFERASE


(Archaeoglobus
fulgidus)
PF02516
(STT3)
5 ILE A 144
ALA A 140
TRP A 413
ALA A 137
ILE A 164
None
1.01A 3fc6A-3wajA:
undetectable
3fc6A-3wajA:
16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wc3 ENDO-1,
4-BETA-GLUCANASE


(Eisenia fetida)
PF00759
(Glyco_hydro_9)
5 ALA A 178
ALA A 177
PHE A  87
ALA A  86
ILE A 332
None
1.02A 3fc6A-3wc3A:
undetectable
3fc6A-3wc3A:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wxw ADIPONECTIN RECEPTOR
PROTEIN 2


(Homo sapiens)
PF03006
(HlyIII)
5 ILE A 322
ALA A 325
ALA A 326
LEU A 283
ALA A 279
None
0.73A 3fc6A-3wxwA:
undetectable
3fc6A-3wxwA:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b8b GENERAL NEGATIVE
REGULATOR OF
TRANSCRIPTION
SUBUNIT 1


(Saccharomyces
cerevisiae)
PF16417
(CNOT1_TTP_bind)
PF16418
(CNOT1_HEAT)
PF16419
(CNOT1_HEAT_N)
5 ILE A 741
ALA A 744
ALA A 745
LEU A 714
ALA A 715
None
0.75A 3fc6A-4b8bA:
undetectable
3fc6A-4b8bA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4djh KAPPA-TYPE OPIOID
RECEPTOR, LYSOZYME


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 ALA A1129
PHE A1153
LEU A1133
ALA A1130
ILE A1078
None
1.00A 3fc6A-4djhA:
undetectable
3fc6A-4djhA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dkl MU-TYPE OPIOID
RECEPTOR, LYSOZYME
CHIMERA


(Escherichia
virus T4;
Mus musculus)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 ALA A1129
PHE A1153
LEU A1133
ALA A1130
ILE A1078
None
1.01A 3fc6A-4dklA:
undetectable
3fc6A-4dklA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g0o PROTEIN ARGONAUTE 5

(Arabidopsis
thaliana)
PF02171
(Piwi)
5 ILE A 629
ALA A 633
ALA A 611
ILE A 653
CYH A 657
None
1.00A 3fc6A-4g0oA:
undetectable
3fc6A-4g0oA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hsc STREPTOLYSIN O

(Streptococcus
pyogenes)
PF01289
(Thiol_cytolysin)
PF17440
(Thiol_cytolys_C)
5 ILE X 557
ALA X 475
GLN X 476
TRP X 499
ILE X 568
None
0.94A 3fc6A-4hscX:
undetectable
3fc6A-4hscX:
17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ia4 AQUAPORIN

(Spinacia
oleracea)
PF00230
(MIP)
5 ALA A 257
ALA A 258
GLN A 261
LEU A 110
ALA A 111
None
0.90A 3fc6A-4ia4A:
undetectable
3fc6A-4ia4A:
22.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4j5x RETINOIC ACID
RECEPTOR RXR-ALPHA,
NUCLEAR RECEPTOR
COACTIVATOR 1


(Homo sapiens)
no annotation 11 ILE D 268
ALA D 271
ALA D 272
GLN D 275
TRP D 305
PHE D 313
ARG D 316
LEU D 326
ALA D 327
ILE D 345
CYH D 432
None
0.63A 3fc6A-4j5xD:
28.7
3fc6A-4j5xD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lde LYSOZYME, BETA-2
ADRENERGIC RECEPTOR


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 ALA A 994
PHE A1018
LEU A 998
ALA A 995
ILE A 943
None
0.96A 3fc6A-4ldeA:
undetectable
3fc6A-4ldeA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nn1 TRANSCRIPTIONAL
REGULATOR


(Mycobacterium
tuberculosis)
PF00440
(TetR_N)
5 ILE A  12
ALA A  15
ALA A  16
GLN A  19
ALA A  35
None
0.59A 3fc6A-4nn1A:
undetectable
3fc6A-4nn1A:
26.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qiq D-XYLOSE-PROTON
SYMPORTER


(Escherichia
coli)
PF00083
(Sugar_tr)
5 ILE A  90
ALA A  91
ALA A  92
LEU A 142
ALA A 143
None
1.00A 3fc6A-4qiqA:
undetectable
3fc6A-4qiqA:
19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qji PHOSPHOPANTOTHENOYLC
YSTEINE
DECARBOXYLASE/PHOSPH
OPANTOTHENATE--CYSTE
INE LIGASE


(Mycolicibacterium
smegmatis)
PF04127
(DFP)
5 ALA A 277
ALA A 196
PHE A 332
ALA A 278
ILE A 405
CTP  A 500 (-4.8A)
None
None
None
None
0.99A 3fc6A-4qjiA:
undetectable
3fc6A-4qjiA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rrj PROBABLE
THREONINE--TRNA
LIGASE 2


(Aeropyrum
pernix)
PF08915
(tRNA-Thr_ED)
5 ILE A  58
ALA A  55
ALA A  54
LEU A  99
ALA A  98
None
0.97A 3fc6A-4rrjA:
undetectable
3fc6A-4rrjA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wtv PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-BETA,ENDOLYSIN,PHO
SPHATIDYLINOSITOL
4-KINASE TYPE 2-BETA


(Escherichia
virus T4;
Homo sapiens)
PF00454
(PI3_PI4_kinase)
PF00959
(Phage_lysozyme)
5 ALA A1128
PHE A1152
LEU A1132
ALA A1129
ILE A1077
None
0.95A 3fc6A-4wtvA:
undetectable
3fc6A-4wtvA:
20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xa8 D-ISOMER SPECIFIC
2-HYDROXYACID
DEHYDROGENASE
NAD-BINDING


(Xanthobacter
autotrophicus)
PF02826
(2-Hacid_dh_C)
5 ILE A 296
ALA A 293
ALA A 292
LEU A  25
ALA A  24
None
0.97A 3fc6A-4xa8A:
undetectable
3fc6A-4xa8A:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xai GRUNGE, ISOFORM J
MALTOSE-BINDING
PERIPLASMIC
PROTEIN,TAILLESS
ORTHOLOG


(Drosophila
melanogaster;
Escherichia
coli;
Tribolium
castaneum)
PF00104
(Hormone_recep)
PF13416
(SBP_bac_8)
no annotation
5 ALA A1204
ALA A1203
GLN A1205
LEU P1820
ALA P1819
None
0.98A 3fc6A-4xaiA:
14.9
3fc6A-4xaiA:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xee NEUROTENSIN RECEPTOR
TYPE 1, ENDOLYSIN
CHIMERA


(Escherichia
virus T4;
Rattus
norvegicus)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 ALA A1129
PHE A1153
LEU A1133
ALA A1130
ILE A1078
None
0.95A 3fc6A-4xeeA:
undetectable
3fc6A-4xeeA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xg0 UNCHARACTERIZED
PROTEIN


(Bordetella
bronchiseptica)
PF07005
(DUF1537)
PF17042
(DUF1357_C)
5 ALA A 322
ALA A 321
LEU A 348
ALA A 347
ILE A 398
None
0.86A 3fc6A-4xg0A:
undetectable
3fc6A-4xg0A:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xgj UNCHARACTERIZED
PROTEIN


(Pectobacterium
atrosepticum)
PF07005
(DUF1537)
PF17042
(DUF1357_C)
6 ILE A 211
ALA A 214
ALA A 215
TRP A  86
LEU A 183
ALA A 184
None
1.34A 3fc6A-4xgjA:
undetectable
3fc6A-4xgjA:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y4m PUTATIVE RIBOSE
1,5-BISPHOSPHATE
ISOMERASE


(Methanocaldococcus
jannaschii)
PF01946
(Thi4)
5 ILE A 132
ALA A 125
ALA A 130
LEU A  49
ILE A 136
None
0.99A 3fc6A-4y4mA:
undetectable
3fc6A-4y4mA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yk2 BARTONELLA EFFECTOR
PROTEIN (BEP)
SUBSTRATE OF VIRB
T4SS


(Bartonella
clarridgeiae)
no annotation 6 ILE A 160
ALA A 156
PHE A 103
LEU A 140
ALA A 141
ILE A 167
None
1.39A 3fc6A-4yk2A:
undetectable
3fc6A-4yk2A:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yxc FLAGELLAR ASSEMBLY
PROTEIN H,ENDOLYSIN


(Escherichia
virus T4;
Salmonella
enterica)
PF00959
(Phage_lysozyme)
5 ALA A 150
PHE A 174
LEU A 154
ALA A 151
ILE A  99
None
1.01A 3fc6A-4yxcA:
undetectable
3fc6A-4yxcA:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zoh PUTATIVE
OXIDOREDUCTASE
FAD-BINDING SUBUNIT


(Sulfurisphaera
tokodaii)
PF00941
(FAD_binding_5)
PF03450
(CO_deh_flav_C)
5 ILE B 236
ALA B 239
ALA B 240
LEU B 226
ALA B 222
None
0.95A 3fc6A-4zohB:
undetectable
3fc6A-4zohB:
25.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bt1 HAT1-INTERACTING
FACTOR 1


(Saccharomyces
cerevisiae)
no annotation 5 ALA A  41
ALA A  42
LEU A  33
ALA A  29
ILE A 245
None
0.78A 3fc6A-5bt1A:
undetectable
3fc6A-5bt1A:
23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bz6 LYSOZYME,CALCIUM
UNIPORTER PROTEIN,
MITOCHONDRIAL


(Escherichia
virus T4;
Homo sapiens)
PF00959
(Phage_lysozyme)
5 ALA A 129
PHE A 153
LEU A 133
ALA A 130
ILE A  78
None
1.02A 3fc6A-5bz6A:
undetectable
3fc6A-5bz6A:
25.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cqf L-LYSINE
6-MONOOXYGENASE


(Pseudomonas
syringae group
genomosp. 3)
PF13434
(K_oxygenase)
5 ILE A 419
ALA A 416
LEU A  25
ALA A  24
ILE A 375
None
1.00A 3fc6A-5cqfA:
undetectable
3fc6A-5cqfA:
17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e6p PLEXIN-B2
RHO GUANINE
NUCLEOTIDE EXCHANGE
FACTOR 11


(Homo sapiens;
Mus musculus)
PF00595
(PDZ)
PF08337
(Plexin_cytopl)
6 ILE A1831
ALA A1834
ALA A1833
GLN B  70
LEU A1835
ILE A1809
None
1.46A 3fc6A-5e6pA:
undetectable
3fc6A-5e6pA:
15.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ee7 GLUCAGON
RECEPTOR,ENDOLYSIN,G
LUCAGON RECEPTOR


(Escherichia
virus T4;
Homo sapiens)
PF00002
(7tm_2)
PF00959
(Phage_lysozyme)
5 ALA A1127
PHE A1151
LEU A1131
ALA A1128
ILE A1076
None
0.97A 3fc6A-5ee7A:
2.3
3fc6A-5ee7A:
17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eut PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA,ENDOLYSIN,PH
OSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA


(Escherichia
virus T4;
Homo sapiens)
PF00454
(PI3_PI4_kinase)
PF00959
(Phage_lysozyme)
5 ALA A1131
PHE A1155
LEU A1135
ALA A1132
ILE A1080
None
0.93A 3fc6A-5eutA:
undetectable
3fc6A-5eutA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5exr DNA POLYMERASE ALPHA
CATALYTIC SUBUNIT


(Homo sapiens)
PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1)
PF08996
(zf-DNA_Pol)
5 ILE C 662
PHE C 622
LEU C 623
ALA C 624
ILE C 639
None
0.95A 3fc6A-5exrC:
undetectable
3fc6A-5exrC:
12.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f2o FATTY ACID
O-METHYLTRANSFERASE


(Mycobacterium
marinum)
PF03492
(Methyltransf_7)
5 ALA A  66
PHE A 104
LEU A 107
ALA A 106
ILE A 138
SAH  A 400 (-3.3A)
None
None
None
None
0.87A 3fc6A-5f2oA:
undetectable
3fc6A-5f2oA:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fmg PROTEASOME SUBUNIT
BETA TYPE


(Plasmodium
falciparum)
PF00227
(Proteasome)
5 ALA I 158
LEU I 138
ALA I 134
ILE I 178
CYH I 176
None
1.02A 3fc6A-5fmgI:
undetectable
3fc6A-5fmgI:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i14 MUTATED AND
TRUNCATED T4
LYSOZYME


(Escherichia
virus T4)
PF00959
(Phage_lysozyme)
5 ALA A  86
PHE A 110
LEU A  90
ALA A  87
ILE A  35
None
0.96A 3fc6A-5i14A:
undetectable
3fc6A-5i14A:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iud DNA POLYMERASE ALPHA
CATALYTIC SUBUNIT


(Homo sapiens)
PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1)
5 ILE A 662
PHE A 622
LEU A 623
ALA A 624
ILE A 639
None
0.88A 3fc6A-5iudA:
undetectable
3fc6A-5iudA:
16.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iuw ALDEHYDE
DEHYDROGENASE FAMILY
PROTEIN


(Pseudomonas
syringae group
genomosp. 3)
no annotation 5 ILE A 294
ALA A 291
ALA A 290
LEU A 326
ALA A 325
None
1.02A 3fc6A-5iuwA:
undetectable
3fc6A-5iuwA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jbw 3-HYDROXYBUTYRYL-COA
DEHYDRATASE


(Myxococcus
xanthus)
PF00378
(ECH_1)
5 ILE A 102
ALA A 101
ALA A 100
ALA A 190
ILE A 166
None
0.97A 3fc6A-5jbwA:
undetectable
3fc6A-5jbwA:
25.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l7a SWI/SNF-RELATED
MATRIX-ASSOCIATED
ACTIN-DEPENDENT
REGULATOR OF
CHROMATIN SUBFAMILY
B MEMBER 1


(Homo sapiens)
PF04855
(SNF5)
5 ILE A 237
ALA A 240
GLN A 244
PHE A 204
ILE A 221
None
1.00A 3fc6A-5l7aA:
undetectable
3fc6A-5l7aA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lnx ACYL-COA
DEHYDROGENASE


(Bacillus
subtilis)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 ILE A  22
ALA A  25
ALA A  26
LEU A  39
ILE A  71
None
0.88A 3fc6A-5lnxA:
undetectable
3fc6A-5lnxA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lva NAD(P)H-FMN
OXIDOREDUCTASE


(Bacillus
subtilis)
PF02525
(Flavodoxin_2)
6 ILE A  60
GLN A  63
PHE A  62
LEU A   6
ALA A   7
ILE A 138
None
1.47A 3fc6A-5lvaA:
undetectable
3fc6A-5lvaA:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mzy GLUTACONATE
COA-TRANSFERASE
FAMILY, SUBUNIT A


(Myxococcus
xanthus)
PF01144
(CoA_trans)
5 ALA A 189
ALA A 190
PHE A 157
LEU A 113
ALA A 116
None
0.95A 3fc6A-5mzyA:
undetectable
3fc6A-5mzyA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n0g PRECORRIN-8X
METHYLMUTASE


(Rhodobacter
capsulatus)
no annotation 5 ILE A  73
ALA A  71
ALA A 130
LEU A  67
ALA A  66
None
0.93A 3fc6A-5n0gA:
undetectable
3fc6A-5n0gA:
18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohs -

(-)
no annotation 5 ILE A 257
ALA A 260
PHE A 541
LEU A 538
ALA A 539
None
0.93A 3fc6A-5ohsA:
undetectable
3fc6A-5ohsA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u2u HEAT SHOCK PROTEIN
104


(Saccharomyces
cerevisiae)
PF02861
(Clp_N)
5 ILE A  14
ALA A  38
ALA A  18
ALA A  37
ILE A 111
None
0.93A 3fc6A-5u2uA:
undetectable
3fc6A-5u2uA:
22.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5uan RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
no annotation 7 ALA A 271
ALA A 272
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 428
9CR  A 503 (-3.5A)
9CR  A 503 (-3.5A)
9CR  A 503 (-4.7A)
9CR  A 503 (-3.0A)
9CR  A 503 (-4.3A)
9CR  A 503 (-3.4A)
None
1.26A 3fc6A-5uanA:
29.9
3fc6A-5uanA:
66.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5uan RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
no annotation 11 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
9CR  A 503 (-4.0A)
9CR  A 503 (-3.5A)
9CR  A 503 (-3.5A)
9CR  A 503 (-3.8A)
None
9CR  A 503 (-4.7A)
9CR  A 503 (-3.0A)
9CR  A 503 (-4.3A)
9CR  A 503 (-3.4A)
None
9CR  A 503 (-3.3A)
0.58A 3fc6A-5uanA:
29.9
3fc6A-5uanA:
66.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vew GLUCAGON-LIKE
PEPTIDE 1
RECEPTOR,ENDOLYSIN
CHIMERA


(Escherichia
virus T4;
Homo sapiens)
PF00002
(7tm_2)
PF00959
(Phage_lysozyme)
5 ALA A1129
PHE A1153
LEU A1133
ALA A1130
ILE A1078
None
1.00A 3fc6A-5vewA:
3.1
3fc6A-5vewA:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xyi RIBOSOMAL PROTEIN
S19E, PUTATIVE


(Trichomonas
vaginalis)
PF01090
(Ribosomal_S19e)
5 ILE T  68
ALA T  65
ALA T  64
LEU T  25
ALA T  26
None
0.87A 3fc6A-5xyiT:
undetectable
3fc6A-5xyiT:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xym 50S RIBOSOMAL
PROTEIN L22


(Mycolicibacterium
smegmatis)
PF00237
(Ribosomal_L22)
5 ILE S  58
ALA S  61
ALA S  62
ALA S  10
ILE S  42
None
0.90A 3fc6A-5xymS:
undetectable
3fc6A-5xymS:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yqr ENDOLYSIN/MEMBRANE-A
NCHORED
LIPID-BINDING
PROTEIN LAM6 FUSION
PROTEIN


(Escherichia
virus T4;
Saccharomyces
cerevisiae)
no annotation 5 ALA A 129
PHE A 153
LEU A 133
ALA A 130
ILE A  78
None
0.98A 3fc6A-5yqrA:
undetectable
3fc6A-5yqrA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cbo C-6'
AMINOTRANSFERASE


(Micromonospora
echinospora)
no annotation 5 ILE A  45
ALA A  34
PHE A 353
ALA A 352
ILE A 365
None
0.90A 3fc6A-6cboA:
undetectable
3fc6A-6cboA:
15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6d95 -

(-)
no annotation 6 ILE A 129
ALA A 132
ALA A 133
LEU A 267
ALA A 266
ILE A 180
None
1.10A 3fc6A-6d95A:
undetectable
3fc6A-6d95A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eux POLYMERASE BASIC
PROTEIN 2


(Influenza B
virus)
no annotation 5 ILE A 312
ALA A 315
ALA A 316
LEU A 505
ILE A 273
None
0.87A 3fc6A-6euxA:
undetectable
3fc6A-6euxA:
17.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f5o POLYMERASE BASIC
PROTEIN 2


(Influenza B
virus)
no annotation 5 ILE C 312
ALA C 315
ALA C 316
LEU C 505
ILE C 273
None
0.90A 3fc6A-6f5oC:
undetectable
3fc6A-6f5oC:
18.60